Harbor Capital Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Harbor Capital Advisors's RMD Position: Q2 2026 in Review
Harbor Capital Advisors increased its ResMed (RMD) stake by 0.22% in Q2 2026, buying an estimated $829 and bringing the position to 1,794 shares worth $350K. The position accounts for 0.02% of the portfolio, ranked #568.
Harbor Capital Advisors first reported a position in RMD in Q1 2023 and has held it in 14 quarters since. The position peaked at $739K in Q3 2024. 539 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Harbor Capital Advisors held 1,794 shares of ResMed worth $350K as of Q2 2026.
- Harbor Capital Advisors bought 4 ResMed shares in Q2 2026, an estimated $829.
- ResMed made up 0.02% of Harbor Capital Advisors's portfolio in Q2 2026, its #568 holding.
- Harbor Capital Advisors first reported a position in ResMed in Q1 2023 and has held it in 14 quarters since.
- Harbor Capital Advisors's ResMed position peaked at $739K in Q3 2024.
- 539 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.